KTTA

Pasithea Therapeutics Corp. [KTTA] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

KTTA Stock Summary

Top 10 Correlated Stocks

KTTA


In the News

09:03 28 Mar 2024 KTTA

Why Is Pasithea Therapeutics (KTTA) Stock Down 12% Today?

Pasithea Therapeutics (NASDAQ: KTTA ) stock is falling on Wednesday after the company's shares experienced major volatility on Tuesday. Investors watching KTTA stock will note that it closed out Tuesday up less than 1%.

11:18 28 Mar 2024 KTTA

Why Is Pasithea Therapeutics (KTTA) Stock Up 105% Today?

Pasithea Therapeutics (NASDAQ: KTTA ) stock is rocketing higher on Monday after the biotechnology company announced results from two preclinical trials of PAS-004. The first study saw positive results from PAS-004 as a treatment for lung cancer.

04:14 28 Mar 2024 KTTA

Pasithea Therapeutics to Participate in H.C. Wainwright 25th Annual Global Investment Conference

-- Attendees may request 1 x 1 meeting with management at meetings@hcwco.com --  PALO ALTO, Calif. and MIAMI, Fla., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research, and development of innovative treatments for central nervous system (CNS) disorders, announced today that Pasithea's management team will participate in the H.C. Wainwright 25th Annual Global Investment Conference, to be held in New York City, September 11-13.

04:16 28 Mar 2024 KTTA

Hot Penny Stocks For Your January 2022 Watchlist

Making a penny stocks watchlist for January? Check these three out The post Hot Penny Stocks For Your January 2022 Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

01:58 28 Mar 2024 KTTA

Top Penny Stocks to Watch During Today's Bull Run

Can these three penny stocks continue to make gains next month? The post Top Penny Stocks to Watch During Today's Bull Run appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

11:35 28 Mar 2024 KTTA

KTTA Stock Alert: 6 Things to Know About Pasithea Therapeutics as Shares Soar Today

Pasithea Therapeutics (KTTA) stock is heading higher on heavy trading Thursday even without any recent news from the biotech company. The post KTTA Stock Alert: 6 Things to Know About Pasithea Therapeutics as Shares Soar Today appeared first on InvestorPlace.

06:07 28 Mar 2024 KTTA

Pasithea Therapeutics (KTTA) Stock: Why The Price Jumped Today

The stock price of Pasithea Therapeutics Corp (NASDAQ: KTTA) increased by over 25% pre-market today. This is why it happened.

09:35 28 Mar 2024 KTTA

Hot Penny Stocks Today: Why Is KTTA Stock Moving?

Shares of penny stock KTTA are on the move and here's what's going on. The post Hot Penny Stocks Today: Why Is KTTA Stock Moving?

08:41 28 Mar 2024 KTTA

Pasithea Therapeutics (KTTA) Stock: Why The Price Surged Today

The stock price of Pasithea Therapeutics Corp (NASDAQ: KTTA) increased by over 135% pre-market today. This is why it happened.

09:13 28 Mar 2024 KTTA

Pasithea Therapeutics Opens its First Ketamine Therapy Clinic in the United Kingdom

Pasithea Clinics partners with ZEN Healthcare – a network of health clinics in Central London – to offer ketamine infusion therapy for the treatment of mental health disorders Ketamine in sub-anesthetic doses has shown to be highly effective at treating some psychiatric disorders, such as treatment resistant depression and post-traumatic stress disorder

KTTA Financial details

Company Rating
Sell
Market Cap
6.98M
Income
-286.41M
Revenue
240.71K
Book val./share
1.13
Cash/share
0.78
Dividend
-
Dividend %
-
Employees
15
Optionable
No
Shortable
Yes
Earnings
30 Mar 2024
P/E
-0.61
Forward P/E
-
PEG
-0
P/S
30.04
P/B
6.15
P/C
9.17
P/FCF
-0.46
Quick Ratio
9.63
Current Ratio
10.16
Debt / Equity
0.01
LT Debt / Equity
0.01
-
-
EPS (TTM)
-10.98
EPS next Y
-
EPS next Q
1.58
EPS this Y
147.62%
EPS next Y
-
EPS next 5Y
29.33%
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-12.5%
SMA50
-
SMA100
-
Inst Own
0.7%
Inst Trans
0.48%
ROA
-934%
ROE
-787%
ROC
-0.56%
Gross Margin
99%
Oper. Margin
-6610%
Profit Margin
-118986%
Payout
-
Shs Outstand
1.04M
Shs Float
745.3K
-
-
-
-
Target Price
-
52W Range
5.26-17.4
52W High
-57.94%
52W Low
+43%
RSI
52
Rel Volume
0.11
Avg Volume
12.95K
Volume
1.48K
Perf Week
5.15%
Perf Month
-1.24%
Perf Quarter
-11.29%
Perf Half Y
-19.3%
-
-
-
-
Beta
0.904
-
-
Volatility
0.17%, 0.31%
Prev Close
0%
Price
7.15
Change
0.7%

KTTA Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K
Revenue per share
000.02
Net income per share
-0.06-0.21-0.52
Operating cash flow per share
-0.06-0.31-0.58
Free cash flow per share
-0.06-0.31-0.66
Cash per share
0.355.091.31
Book value per share
0.354.941.68
Tangible book value per share
0.354.941.29
Share holders equity per share
0.354.941.68
Interest debt per share
000.04
Market cap
49.05M368.33M324.23M
Enterprise value
48.81M315.36M292.01M
P/E ratio
-1.2K-169.42-24.83
Price to sales ratio
024.45K666.38
POCF ratio
-1.27K-116.04-22.27
PFCF ratio
-1.27K-115.26-19.41
P/B Ratio
203.237.167.63
PTB ratio
203.237.167.63
EV to sales
020.94K600.16
Enterprise value over EBITDA
-1.19K-69.99-19.81
EV to operating cash flow
-1.26K-99.36-20.05
EV to free cash flow
-1.26K-98.69-17.49
Earnings yield
0-0.01-0.04
Free cash flow yield
0-0.01-0.05
Debt to equity
000.02
Debt to assets
000.02
Net debt to EBITDA
5.9511.752.19
Current ratio
37.55119.1718.15
Interest coverage
0-8.87K-145.26K
Income quality
0.941.461.04
Dividend Yield
000
Payout ratio
000
Sales general and administrative to revenue
000
Research and developement to revenue
005.48
Intangibles to total assets
000.22
Capex to operating cash flow
00.010.15
Capex to revenue
0-1.43-4.4
Capex to depreciation
0-15.59-66.06
Stock based compensation to revenue
031.291.14
Graham number
0.684.824.42
ROIC
0.08-0.09-0.31
Return on tangible assets
-0.17-0.04-0.37
Graham Net
0.344.911.22
Working capital
241.36K52.85M32.2M
Tangible asset value
241.36K51.42M32.65M
Net current asset value
241.36K51.4M31.39M
Invested capital
000.02
Average receivables
00151.07K
Average payables
0226.94K1.03M
Average inventory
000.5
Days sales outstanding
00226.65
Days payables outstanding
09.45K5.21K
Days of inventory on hand
000
Receivables turnover
001.61
Payables turnover
00.040.07
Inventory turnover
00113.2K
ROE
-0.17-0.04-0.31
Capex per share
00-0.08

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.010.01000
Net income per share
-0.2-0.15-10.55-0.14-0.14
Operating cash flow per share
-0.2-0.17-0.12-0.13-0.11
Free cash flow per share
-0.2-0.25-0.12-0.13-0.1
Cash per share
1.61.311.151.020.78
Book value per share
1.761.681.51.361.13
Tangible book value per share
1.621.291.1310.76
Share holders equity per share
1.761.681.51.361.13
Interest debt per share
0.050.040.030.020.02
Market cap
669.03M324.23M195.55M256.05M241.55M
Enterprise value
627.61M292.01M166.36M229.97M222.35M
P/E ratio
-31.82-20.77-0.18-17.01-16.72
Price to sales ratio
3.06K1.35K000
POCF ratio
-127.71-73.38-61.07-73.59-90.99
PFCF ratio
-123.07-52.23-60.05-73.53-91.77
P/B Ratio
14.37.6357.198.51
PTB ratio
14.37.6357.198.51
EV to sales
2.87K1.21K000
Enterprise value over EBITDA
-160.97-70.12-54.53-60.84-58.68
EV to operating cash flow
-119.8-66.09-51.95-66.09-83.76
EV to free cash flow
-115.45-47.04-51.09-66.04-84.48
Earnings yield
-0.01-0.01-1.41-0.01-0.01
Free cash flow yield
-0.01-0.02-0.02-0.01-0.01
Debt to equity
0.020.020.020.020.01
Debt to assets
0.020.020.020.010.01
Net debt to EBITDA
10.627.749.576.95.07
Current ratio
29.3718.1514.6612.5810.16
Interest coverage
-12.68-49.81K-502.900
Income quality
1.140.860.980.970.73
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
5.35.76000
Intangibles to total assets
0.080.220.230.250.31
Capex to operating cash flow
0.040.40.020-0.01
Capex to revenue
-0.9-7.43000
Capex to depreciation
-11.8418.44K-0.33-0.020.14
Stock based compensation to revenue
-1.360.65000
Graham number
2.82.4218.882.11.91
ROIC
-0.1-0.09-6.71-0.1-0.12
Return on tangible assets
-0.11-0.11-8.5-0.13-0.17
Graham Net
1.491.221.050.940.71
Working capital
42.96M32.2M28.99M25.81M18.73M
Tangible asset value
42.92M32.65M29.46M26.07M19.01M
Net current asset value
41.65M31.39M28.2M25.48M18.49M
Invested capital
0.020.020.020.020.01
Average receivables
0151.07K158.96K69.14K108.75K
Average payables
627.98K1.44M1.53M1.69M963.02K
Average inventory
00.5460.24K867.53K899.82K
Days sales outstanding
0112.96000
Days payables outstanding
1.31K111.08K800.831.06K0
Days of inventory on hand
00.07509.24449.17546.4
Receivables turnover
00.8000
Payables turnover
0.0700.110.080
Inventory turnover
01.31K0.180.20.16
ROE
-0.11-0.09-7.03-0.11-0.13
Capex per share
-0.01-0.07000

KTTA Frequently Asked Questions

What is Pasithea Therapeutics Corp. stock symbol ?

Pasithea Therapeutics Corp. is a US stock , located in Miami beach of Fl and trading under the symbol KTTA

What is Pasithea Therapeutics Corp. stock quote today ?

Pasithea Therapeutics Corp. stock price is $7.15 today.

Is Pasithea Therapeutics Corp. stock public?

Yes, Pasithea Therapeutics Corp. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks
Similar Market Cap